Paper-based HIV self test

纸质 HIV 自检

基本信息

  • 批准号:
    10373830
  • 负责人:
  • 金额:
    $ 47.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-25 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

Abstract: Current self-tests for HIV rely on detection of antibodies to the virus, and thus are not useful during the early stages of infection. These assays are also not appropriate for patients on antiretroviral therapy who may be at risk for viral rebound, as pre-existing anti-HIV antibodies mask changes in viral load. Conversely, current HIV diagnostics based on detection of viral RNA are sensitive, but too complex and expensive to be appropriate for self-testing. To address this critical need, we will develop the first enzyme-free sample-to-answer HIV viral load self-test, in which a fingerstick volume of blood is passively processed leading to amplification of the isolated HIV genomic RNA. The RNA amplification strategy will rely on hairpin cascade reactions (HCR), a DNA nanotechnology approach with proven single-copy sensitivity in other contexts, in a sessile droplet implementation. The entire assay will be implemented in an inexpensive, disposable, paper-based consumable. In the R61 phase, we propose to: (1) building on methods we have previously validated, optimize passive processing of whole blood coupled with paper-based viral lysis and RNA isolation; (2) complete development of HCR-based amplification of HIV genomic RNA; (3) integrate sample processing and RNA amplification into a single consumable; and (4) obtain feedback on assay design and usability from patients at risk for HIV infection, and develop a pilot manufacturing plan. In the R33 phase, we will (1) scale production of the assay with contract manufacturers in quantities suitable for pilot testing, and (2) complete testing of the assay with a cohort of 1000 patients at-risk for HIV infection, recruited from patients visiting the Emergency Department at the University of Rochester Medical Center.
翻译后摘要:目前的自我测试艾滋病毒依赖于检测抗体的病毒,因此不是 在感染的早期阶段是有用的。这些测定也不适合接受以下治疗的患者 抗逆转录病毒治疗可能存在病毒反弹风险,因为预先存在抗HIV抗体 掩盖病毒载量的变化相反,目前基于病毒RNA检测的HIV诊断 是敏感的,但太复杂和昂贵,不适合自我测试。为了解决这个 关键的需要,我们将开发第一个无酶样品回答艾滋病毒载量自我测试,在 其中手指针刺体积的血液被被动处理,导致分离的 HIV基因组RNA。RNA扩增策略将依赖于发夹级联反应(HCR), 一种DNA纳米技术方法,在其他情况下具有已证明的单拷贝灵敏度, 液滴实现。整个测定将在廉价的、一次性的、 纸质耗材。在R61阶段,我们建议:(1)建立在我们已有的方法基础上 先前已验证,优化全血的被动处理加上纸基病毒 裂解和RNA分离;(2)完成基于HCR的HIV基因组扩增 (3)将样品处理和RNA扩增集成到单个消耗品中;以及(4) 从有HIV感染风险的患者那里获得关于检测设计和可用性的反馈,并开发 一个试验性的生产计划在R33阶段,我们将(1)使用以下试剂盒进行规模生产 合同制造商,数量适合于中试测试,以及(2)完成分析测试 与1000名艾滋病毒感染风险患者的队列,从访问的患者招募, 罗切斯特大学医学中心急诊科。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin L Miller其他文献

A patch for a splice
一个用于接头的补片
  • DOI:
    10.1038/nchembio.1839
  • 发表时间:
    2015-06-17
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Benjamin L Miller
  • 通讯作者:
    Benjamin L Miller

Benjamin L Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin L Miller', 18)}}的其他基金

Paper-based HIV self test
纸质 HIV 自检
  • 批准号:
    10555209
  • 财政年份:
    2022
  • 资助金额:
    $ 47.2万
  • 项目类别:
Osteoimmunology Core
骨免疫学核心
  • 批准号:
    10402965
  • 财政年份:
    2017
  • 资助金额:
    $ 47.2万
  • 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
  • 批准号:
    8550102
  • 财政年份:
    2012
  • 资助金额:
    $ 47.2万
  • 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
  • 批准号:
    8737913
  • 财政年份:
    2012
  • 资助金额:
    $ 47.2万
  • 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
  • 批准号:
    8259290
  • 财政年份:
    2012
  • 资助金额:
    $ 47.2万
  • 项目类别:
RNA Targeted Small Molecules: Connecting Binding Kinetics to Sequence Selectivity
RNA 靶向小分子:将结合动力学与序列选择性联系起来
  • 批准号:
    8914807
  • 财政年份:
    2012
  • 资助金额:
    $ 47.2万
  • 项目类别:
Preclinical Development of Lead Compounds Targeting Myotonic Dystrophy
针对强直性肌营养不良的先导化合物的临床前开发
  • 批准号:
    7963320
  • 财政年份:
    2010
  • 资助金额:
    $ 47.2万
  • 项目类别:
Preclinical Development of Lead Compounds Targeting Myotonic Dystrophy
针对强直性肌营养不良的先导化合物的临床前开发
  • 批准号:
    8109327
  • 财政年份:
    2010
  • 资助金额:
    $ 47.2万
  • 项目类别:
Photonic structures for direct ultrasensitive virus detection
用于直接超灵敏病毒检测的光子结构
  • 批准号:
    8029557
  • 财政年份:
    2009
  • 资助金额:
    $ 47.2万
  • 项目类别:
Photonic structures for direct ultrasensitive virus detection
用于直接超灵敏病毒检测的光子结构
  • 批准号:
    8238366
  • 财政年份:
    2009
  • 资助金额:
    $ 47.2万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.2万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了